Follow-up of Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorHumanity and Health Research Centre
About this trial
The purpose of this study is to determine the disease progression in CHB/NAFLD compared with CHB and NAFLD including liver cirrhosis, cirrhotic complications and hepatocellular carcinoma (HCC).
Eligibility criteria
Qualifiers
Liver biopsy proved CHB and/or NAFLD at baseline;
Chinese
Follow-up duration>12 months
Disqualifiers
Other liver diseases;
Secondary causes of hepatic steatosis;
Alcohol abuse;
Liver cirrhosis, cirrhosis related complications or HCC at baseline;
Trial design
Treatments tested in this trial
- Not listed
Trial groups
1,500 Participants
are grouped into 3 trial groupsSponsors and collaborators
Source ClinicalTrials.gov